• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 61-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
112-8128139-4/1/1 22-Sep-2005 61CCP99 3004184545 Maquet Critical Care Ab Sweden
 
112-8128139-4/1/2 22-Sep-2005 61CCP99 3004184545 Maquet Critical Care Ab Sweden
 
112-7541712-9/1/1 03-Sep-2005 61DIB99 1000583309 CV Therapeautics Inc United States
 
112-7330441-0/1/1 07-Sep-2005 61ECK01 3005173954 Aft Pharmaceutical New Zealand
 
112-8202566-7/1/1 26-Sep-2005 61EIL04 3003159490 Eurolabs Limited United Kingdom
 
112-8173689-2/1/1 22-Sep-2005 61FCB54 3005291983 Pharmachen Ltd Greece
 
K10-3529436-8/1/1 20-Sep-2005 61FCS54 3003448273 Neuland Laboratories Limited India
 
112-8059515-8/1/2 28-Sep-2005 61FCY42 3005192567 Schering Venezuela
 
112-8059515-8/1/3 28-Sep-2005 61FCY42 3005192567 Schering Venezuela
 
AEK-6675337-3/1/1 26-Sep-2005 61FIS56 3005250533 Beijing Pewiyond Pharmaceuticals China
 
112-7948525-4/2/1 15-Sep-2005 61GCN40 3004458023 Aventis Pharmaceutical France
 
H77-0096061-7/1/1 27-Sep-2005 61GCU57 3003649250 Virchow Laboratories Ltd. India
 
AR8-0029383-9/6/1/D 09-Sep-2005 61HAL99 3004706890 Ooo Protek-50 Russia
 
112-8076307-9/2/1 12-Sep-2005 61HBL99 3003198686 Vivier Pharma, Inc. Canada
 
112-8059515-8/1/1 28-Sep-2005 61HCE32 3005106102 Lab Pharma Venezuela Venezuela
 
112-7948525-4/1/1 15-Sep-2005 61HCN99 3002806523 Sandoz GmbH (Tirol) Austria
 
112-8188050-0/2/1 26-Sep-2005 61HDB99 3002807756 Teva Canada Limited Canada
 
AEK-7048310-8/1/1 22-Sep-2005 61HIR99 3004568282 Instituto Cientifico Spain
 
112-7343904-2/2/3 08-Sep-2005 61JCA08 2416101 Pfizer Inc. United States
 
433-0282182-2/1/1 13-Sep-2005 61JCS11 3002808161 Signa SA de CV Mexico
 
112-7589491-3/2/1 09-Sep-2005 61JDP12 3004756138 Laboratorios Rowie C Por A Dominican Republic
 
112-7935412-0/1/1 15-Sep-2005 61JQY10 3001743983 Novartis Farmaceutica S.A. De C.V. Mexico
 
112-8112532-8/1/1 27-Sep-2005 61KAL09 3005283570 Om Peru Sa Peru
 
AR8-0029383-9/6/1/H 09-Sep-2005 61LCJ30 3004706890 Ooo Protek-50 Russia
 
112-7967705-8/1/2 02-Sep-2005 61LDB38 3005264135 Sanofi Philippines
 
112-7457447-4/5/1 08-Sep-2005 61MCA30 3004886854 Avanti Pharma Peru
 
112-8426947-9/1/1 26-Sep-2005 61MCA38 3004979468 Glaxosmithkline S.A. Brazil
 
112-7982024-5/1/1 18-Sep-2005 61MCA40 3002806695 Cilag AG Switzerland
 
112-8351907-2/1/1 30-Sep-2005 61MCB99 3005316032 Parke Davis Sl Spain
 
112-8173855-9/1/1 25-Sep-2005 61NAL79 3004427963 Aventis Pharma Ag Switzerland
 
112-7408816-0/1/1 07-Sep-2005 61NCA66 3005185876 Gaby Olivares Chile
 
AEK-7057052-4/1/1 26-Sep-2005 61NCB23 3005251301 Damien Pv India
 
112-7457447-4/2/1 08-Sep-2005 61NCB83 3005192089 Abbott Laboratories Guatemala
 
AEK-7057052-4/1/2 26-Sep-2005 61NCB83 3005251301 Damien Pv India
 
112-7457447-4/1/1 08-Sep-2005 61NCB99 3005192093 Pharmacia & Upjohn Venezuela
 
AEK-7057052-4/1/3 26-Sep-2005 61NCB99 3005251301 Damien Pv India
 
112-8188050-0/3/1 26-Sep-2005 61NDB78 1000607714 Pfizer Canada Inc Canada
 
112-7757855-5/1/1 13-Sep-2005 61PAA99 3005234105 Biovat Israel
 
112-7343904-2/2/1 08-Sep-2005 61PCA26 1000645857 Bristol-Meyers Squibb Co United States
 
112-7343904-2/2/2 08-Sep-2005 61PCA61 1000370775 Smithkline Beecham Pharmaceuti United States
 
112-7343904-2/1/1 07-Sep-2005 61PCA99 3003817683 Aventis Pharma Switzerland
 
DO7-0097712-0/1/1 15-Sep-2005 61PCB11 3003548358 Navin Patel India
 
112-7637630-8/1/1 09-Sep-2005 61PIS17 3004181833 Saiet Srl Italy
 
112-8242459-7/1/1 26-Sep-2005 61QRY99 3005300918 Pj Warssan Fayar Indonesia
 
112-7640802-8/1/1 09-Sep-2005 61SBA99 3005217217 Dr. Wakeel Ahmed Pakistan
 
112-7804248-6/1/2 14-Sep-2005 61SCO99 3005040810 Pfizer Inc South Africa
 
112-8204744-8/1/1 28-Sep-2005 61TAY99 3003357250 Ciatti Europe France
 
112-7394443-9/1/1 07-Sep-2005 61TBA28 3001075251 Glaxo Wellcome Egypt
 
112-7425210-5/1/1 08-Sep-2005 61TBA99 3002625923 Random House Uk Limited United Kingdom
 
112-7307784-2/1/7 06-Sep-2005 61TCA12 3005007448 Laboratorios Elmor Sa Venezuela
 
112-7950972-3/2/1 15-Sep-2005 61TCA12 3004562359 Biotech Laboratories Venezuela
 
112-7950972-3/3/1 15-Sep-2005 61TCA12 3005095119 Sanofi-Synthe Labo Colombia
 
112-7656162-8/1/1 13-Sep-2005 61TCH01 3004707009 Labs Sanof Colombia
 
AEK-7056493-1/1/1 15-Sep-2005 61UCA05 3005245504 Osvaldo Ottavio Lagana Egypt
 
112-8011465-3/1/1 20-Sep-2005 61VCA01 3005269139 Birzeit-Palestine Pharm Co Bpc Israel
 
112-8372247-8/1/1 29-Sep-2005 61VIA99 3004075481 Ratiopharm Canada
 
112-7588908-7/1/1 08-Sep-2005 61WAH04 1000380439 Bayer Diagnostics Uk Limited United Kingdom
 
112-7588908-7/1/2 08-Sep-2005 61WAK04 1000380439 Bayer Diagnostics Uk Limited United Kingdom
 
110-2116071-2/1/1 06-Sep-2005 61WCE46 1000597252 Ningbo Free Trade Zone Trust China
 
112-8266641-1/1/1 25-Sep-2005 61WCK31 3005304585 3m Columbia S.A. Colombia
 
112-7804248-6/1/1 14-Sep-2005 61WCO45 3005040810 Pfizer Inc South Africa
 
112-7609911-6/1/1 01-Sep-2005 61XAA05 3004207397 International Pharmaceuticals Philippines
 
336-0510489-5/1/1 01-Sep-2005 61XBB08 3002807186 Valeant Pharmaceuticals International Canada
 
336-0510489-5/2/1 01-Sep-2005 61XBB08 3002807186 Valeant Pharmaceuticals International Canada
 
112-7655402-9/1/2 13-Sep-2005 61XBC37 3003516629 Pfizer Laboratoriesfse Comptabilite Fourniss France
 
112-7655402-9/1/1 13-Sep-2005 61XBL04 3000942695 Whitehall France
 
336-2838022-5/1/1 22-Sep-2005 61XBS04 3005236249 Bristol Myers Squibb Egypt Egypt
 
112-7332271-9/1/1 07-Sep-2005 61XCA14 1000168130 Merck Sharp & Dohme Limited United Kingdom
 
AEK-7060829-0/1/1 01-Sep-2005 61XCA99 3005282917 Mussa Abdulhah Al-Radaar Yemen
 
112-7966745-5/1/1 15-Sep-2005 61XCP09 3003827525 Jansen Cilag S.A.De C.V. Mexico
 
112-7510812-4/1/1 08-Sep-2005 61XCY45 3005199381 Percos S.A. Colombia
 
-
-